Arun Srivastava , PhD - Publications

University of Florida, Gainesville, Gainesville, FL, United States 

86 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Yang H, Qing K, Keeler GD, Yin L, Mietzsch M, Ling C, Hoffman BE, Agbandje-McKenna M, Tan M, Wang W, Srivastava A. Enhanced Transduction of Human Hematopoietic Stem Cells by AAV6 Vectors: Implications in Gene Therapy and Genome Editing. Molecular Therapy. Nucleic Acids. 20: 451-458. PMID 32276210 DOI: 10.1016/j.omtn.2020.03.009  0.44
2020 Ran G, Chen X, Xie Y, Zheng Q, Xie J, Yu C, Pittman N, Qi S, Yu FX, Agbandje-McKenna M, Srivastava A, Ling C. Site-Directed Mutagenesis Improves the Transduction Efficiency of Capsid Library-Derived Recombinant AAV Vectors. Molecular Therapy. Methods & Clinical Development. 17: 545-555. PMID 32258217 DOI: 10.1016/j.omtm.2020.03.007  0.44
2020 Yin L, Keeler GD, Zhang Y, Hoffman BE, Ling C, Qing K, Srivastava A. AAV3-miRNA vectors for growth suppression of human hepatocellular carcinoma cells in vitro and human liver tumors in a murine xenograft model in vivo. Gene Therapy. PMID 32152434 DOI: 10.1038/s41434-020-0140-1  0.44
2019 Berns KI, Srivastava A. Next Generation of Adeno-Associated Virus Vectors for Gene Therapy for Human Liver Diseases. Gastroenterology Clinics of North America. 48: 319-330. PMID 31046978 DOI: 10.1016/j.gtc.2019.02.005  0.88
2019 Agbandje-McKenna M, Srivastava A. XVIIth International Parvovirus Workshop. Human Gene Therapy. PMID 30807259 DOI: 10.1089/hum.2019.29084.mam  0.44
2018 Feng Y, Yin Z, Zhang D, Srivastava A, Ling C. Chinese medicine protein and peptide in gene and cell therapy. Current Protein & Peptide Science. PMID 29895243 DOI: 10.2174/1389203719666180612082432  0.44
2017 Rogers GL, Shirley JL, Zolotukhin I, Kumar SRP, Sherman A, Perrin GQ, Hoffman BE, Srivastava A, Basner-Tschakarjan E, Wallet MA, Terhorst C, Biswas M, Herzog RW. Plasmacytoid and conventional dendritic cells cooperate in crosspriming AAV capsid-specific CD8(+) T cells. Blood. 129: 3184-3195. PMID 28468798 DOI: 10.1182/blood-2016-11-751040  0.4
2017 Markusic DM, Nichols TC, Merricks EP, Palaschak B, Zolotukhin I, Marsic D, Zolotukhin S, Srivastava A, Herzog RW. Evaluation of engineered AAV capsids for hepatic factor IX gene transfer in murine and canine models. Journal of Translational Medicine. 15: 94. PMID 28460646 DOI: 10.1186/s12967-017-1200-1  0.44
2017 Chen M, Maeng K, Nawab A, Francois RA, Bray JK, Reinhard MK, Boye SL, Hauswirth WW, Kaye FJ, Aslanidi GV, Srivastava A, Zajac-Kaye M. Efficient Gene Delivery and Expression in Pancreas and Pancreatic Tumors by Capsid-optimized AAV8 Vectors. Human Gene Therapy Methods. PMID 28125909 DOI: 10.1089/hgtb.2016.089  0.44
2016 Ling C, Bhukhai K, Yin Z, Tan M, Yoder MC, Leboulch P, Payen E, Srivastava A. High-Efficiency Transduction of Primary Human Hematopoietic Stem/Progenitor Cells by AAV6 Vectors: Strategies for Overcoming Donor-Variation and Implications in Genome Editing. Scientific Reports. 6: 35495. PMID 27759036 DOI: 10.1038/srep35495  0.44
2016 Srivastava A. In vivo tissue-tropism of adeno-associated viral vectors. Current Opinion in Virology. 21: 75-80. PMID 27596608 DOI: 10.1016/j.coviro.2016.08.003  0.72
2016 Ling C, Li B, Ma W, Srivastava A. Development of Optimized AAV Serotype Vectors for High-Efficiency Transduction at Further Reduced Doses. Human Gene Therapy Methods. PMID 27431826 DOI: 10.1089/hgtb.2016.054  0.36
2016 Rosario AM, Cruz PE, Ceballos-Diaz C, Strickland MR, Siemienski Z, Pardo M, Schob KL, Li A, Aslanidi GV, Srivastava A, Golde TE, Chakrabarty P. Microglia-specific targeting by novel capsid-modified AAV6 vectors. Molecular Therapy. Methods & Clinical Development. 3: 16026. PMID 27308302 DOI: 10.1038/mtm.2016.26  0.44
2016 Ling C, Yin Z, Li J, Zhang D, Aslanidi G, Srivastava A. Strategies to generate high-titer, high-potency recombinant AAV3 serotype vectors. Molecular Therapy. Methods & Clinical Development. 3: 16029. PMID 27200382 DOI: 10.1038/mtm.2016.29  0.44
2016 Srivastava A. Adeno-Associated Virus: The Naturally Occurring Virus Versus the Recombinant Vector Human Gene Therapy. 27: 1-6. DOI: 10.1089/hum.2015.29017.asr  0.72
2015 Ling C, Wang Y, Lu Y, Wang L, Jayandharan GR, Aslanidi GV, Li B, Cheng B, Ma W, Lentz T, Ling C, Xiao X, Samulski RJ, Muzyczka N, Srivastava A. The Adeno-Associated Virus Genome Packaging Puzzle. Journal of Molecular and Genetic Medicine : An International Journal of Biomedical Research. 9. PMID 26949410 DOI: 10.4172/1747-0862.1000175  0.88
2015 Berns KI, Byrne BJ, Flotte TR, Gao G, Hauswirth WW, Herzog RW, Muzyczka N, VandenDriessche T, Xiao X, Zolotukhin S, Srivastava A. Adeno-Associated Virus Type 2 and Hepatocellular Carcinoma? Human Gene Therapy. 26: 779-81. PMID 26690810 DOI: 10.1089/hum.2015.29014.kib  0.88
2015 Srivastava A, Li B, Ma W, Ling C, Van Vliet K, Huang LY, Agbandje-McKenna M, Aslanidi GV. Site-directed mutagenesis of surface-exposed lysine residues leads to improved transduction by AAV2, but not AAV8 vectors in murine hepatocytes in vivo. Human Gene Therapy Methods. PMID 26421998 DOI: 10.1089/hgtb.2015.115  0.72
2015 Li S, Ling C, Zhong L, Li M, Su Q, He R, Tang Q, Greiner DL, Shultz LD, Brehm MA, Flotte TR, Mueller C, Srivastava A, Gao G. Efficient and targeted transduction of nonhuman primate liver with systemically delivered optimized AAV3B vectors. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 26403887 DOI: 10.1038/mt.2015.174  0.72
2015 Ling C, Wang Y, Feng YL, Zhang YN, Li J, Hu XR, Wang LN, Zhong MF, Zhai XF, Zolotukhin I, Srivastava A, Ling CQ. Prevalence of neutralizing antibodies against liver-tropic adeno-associated virus serotype vectors in 100 healthy Chinese and its potential relation to body constitutions. Journal of Integrative Medicine. 13: 341-6. PMID 26343106 DOI: 10.1016/S2095-4964(15)60200-X  0.72
2015 Wang L, Yin Z, Wang Y, Lu Y, Zhang D, Srivastava A, Ling C, Aslanidi GV, Ling C. Productive life cycle of adeno-associated virus serotype 2 in the complete absence of a conventional polyadenylation signal. The Journal of General Virology. 96: 2780-7. PMID 26297494 DOI: 10.1099/jgv.0.000229  0.72
2015 Ling C, Wang Y, Lu Y, Wang L, Jayandharan GR, Aslanidi GV, Li B, Cheng B, Ma W, Lentz T, Ling C, Xiao X, Samulski RJ, Muzyczka N, Srivastava A. Enhanced transgene expression from recombinant single-stranded D-sequence-substituted adeno-associated virus vectors in human cell lines in vitro and in murine hepatocytes in vivo. Journal of Virology. 89: 952-61. PMID 25355884 DOI: 10.1128/JVI.02581-14  0.72
2014 Zhang YH, Wang Y, Yusufali AH, Ashby F, Zhang D, Yin ZF, Aslanidi GV, Srivastava A, Ling CQ, Ling C. Cytotoxic genes from traditional Chinese medicine inhibit tumor growth both in vitro and in vivo. Journal of Integrative Medicine. 12: 483-94. PMID 25412666 DOI: 10.1016/10.1016/S2095-4964(14)60057-1  0.44
2014 Ling C, Wang Y, Zhang Y, Ejjigani A, Yin Z, Lu Y, Wang L, Wang M, Li J, Hu Z, Aslanidi GV, Zhong L, Gao G, Srivastava A, Ling C. Selective in vivo targeting of human liver tumors by optimized AAV3 vectors in a murine xenograft model. Human Gene Therapy. 25: 1023-34. PMID 25296041 DOI: 10.1089/hum.2014.099  0.72
2014 Wang LN, Wang Y, Lu Y, Yin ZF, Zhang YH, Aslanidi GV, Srivastava A, Ling CQ, Ling C. Pristimerin enhances recombinant adeno-associated virus vector-mediated transgene expression in human cell lines in vitro and murine hepatocytes in vivo. Journal of Integrative Medicine. 12: 20-34. PMID 24461592 DOI: 10.1016/S2095-4964(14)60003-0  0.44
2014 Batchu RB, Gruzdyn OV, Moreno-Bost AM, Szmania S, Jayandharan G, Srivastava A, Kolli BK, Weaver DW, van Rhee F, Gruber SA. Efficient lysis of epithelial ovarian cancer cells by MAGE-A3-induced cytotoxic T lymphocytes using rAAV-6 capsid mutant vector. Vaccine. 32: 938-43. PMID 24406390 DOI: 10.1016/j.vaccine.2013.12.049  0.72
2014 Ten E, Ling C, Wang Y, Srivastava A, Dempere LA, Vermerris W. Lignin nanotubes as vehicles for gene delivery into human cells. Biomacromolecules. 15: 327-38. PMID 24308459 DOI: 10.1021/bm401555p  0.72
2014 Chen MJ, Lu Y, Hamazaki T, Tsai HY, Erger K, Conlon T, Elshikha AS, Li H, Srivastava A, Yao C, Brantly M, Chiodo V, Hauswirth W, Terada N, Song S. Reprogramming adipose tissue-derived mesenchymal stem cells into pluripotent stem cells by a mutant adeno-associated viral vector Human Gene Therapy Methods. 25: 72-82. PMID 24191859 DOI: 10.1089/hgtb.2013.011  0.72
2013 Tartaglia LJ, Bennett A, Plattner AS, Muzyczka N, Ling C, Srivastava A, Agbandje-McKenna M. Molecular cloning, overexpression, and an efficient one-step purification of α5β1 integrin. Protein Expression and Purification. 92: 21-8. PMID 23993979 DOI: 10.1016/j.pep.2013.08.013  0.72
2013 Song L, Kauss MA, Kopin E, Chandra M, Ul-Hasan T, Miller E, Jayandharan GR, Rivers AE, Aslanidi GV, Ling C, Li B, Ma W, Li X, Andino LM, Zhong L, et al. Optimizing the transduction efficiency of capsid-modified AAV6 serotype vectors in primary human hematopoietic stem cells in vitro and in a xenograft mouse model in vivo. Cytotherapy. 15: 986-98. PMID 23830234 DOI: 10.1016/j.jcyt.2013.04.003  0.72
2013 Aslanidi GV, Rivers AE, Ortiz L, Song L, Ling C, Govindasamy L, Van Vliet K, Tan M, Agbandje-McKenna M, Srivastava A. Optimization of the capsid of recombinant adeno-associated virus 2 (AAV2) vectors: the final threshold? Plos One. 8: e59142. PMID 23527116 DOI: 10.1371/journal.pone.0059142  0.44
2013 Song L, Li X, Jayandharan GR, Wang Y, Aslanidi GV, Ling C, Zhong L, Gao G, Yoder MC, Ling C, Tan M, Srivastava A. High-efficiency transduction of primary human hematopoietic stem cells and erythroid lineage-restricted expression by optimized AAV6 serotype vectors in vitro and in a murine xenograft model in vivo. Plos One. 8: e58757. PMID 23516552 DOI: 10.1371/journal.pone.0058757  0.72
2012 Zhong L, Jayandharan GR, Aslanidi GV, Zolotukhin S, Herzog RW, Srivastava A. Development of Novel Recombinant AAV Vectors and Strategies for the Potential Gene Therapy of Hemophilia. Journal of Genetic Syndromes & Gene Therapy. PMID 23264889 DOI: 10.4172/2157-7412.S1-008  0.44
2012 Wang Y, Ling C, Song L, Wang L, Aslanidi GV, Tan M, Ling C, Srivastava A. Limitations of encapsidation of recombinant self-complementary adeno-associated viral genomes in different serotype capsids and their quantitation. Human Gene Therapy Methods. 23: 225-33. PMID 22966785 DOI: 10.1089/hgtb.2012.090  0.44
2012 Aslanidi GV, Rivers AE, Ortiz L, Govindasamy L, Ling C, Jayandharan GR, Zolotukhin S, Agbandje-McKenna M, Srivastava A. High-efficiency transduction of human monocyte-derived dendritic cells by capsid-modified recombinant AAV2 vectors. Vaccine. 30: 3908-17. PMID 22497875 DOI: 10.1016/j.vaccine.2012.03.079  0.44
2012 Cheng B, Ling C, Dai Y, Lu Y, Glushakova LG, Gee SW, McGoogan KE, Aslanidi GV, Park M, Stacpoole PW, Siemann D, Liu C, Srivastava A, Ling C. Development of optimized AAV3 serotype vectors: mechanism of high-efficiency transduction of human liver cancer cells. Gene Therapy. 19: 375-84. PMID 21776025 DOI: 10.1038/gt.2011.105  0.72
2011 Rogers GL, Martino AT, Aslanidi GV, Jayandharan GR, Srivastava A, Herzog RW. Innate Immune Responses to AAV Vectors. Frontiers in Microbiology. 2: 194. PMID 21954398 DOI: 10.3389/fmicb.2011.00194  0.44
2011 Ling C, Lu Y, Cheng B, McGoogan KE, Gee SW, Ma W, Li B, Aslanidi GV, Srivastava A. High-efficiency transduction of liver cancer cells by recombinant adeno-associated virus serotype 3 vectors. Journal of Visualized Experiments : Jove. PMID 21445055 DOI: 10.3791/2538  0.72
2011 Chen KA, Cruz PE, Lanuto DJ, Flotte TR, Borchelt DR, Srivastava A, Zhang J, Steindler DA, Zheng T. Cellular fusion for gene delivery to SCA1 affected Purkinje neurons. Molecular and Cellular Neurosciences. 47: 61-70. PMID 21420496 DOI: 10.1016/j.mcn.2011.03.003  0.72
2011 Jayandharan GR, Aslanidi G, Martino AT, Jahn SC, Perrin GQ, Herzog RW, Srivastava A. Activation of the NF-kappaB pathway by adeno-associated virus (AAV) vectors and its implications in immune response and gene therapy. Proceedings of the National Academy of Sciences of the United States of America. 108: 3743-8. PMID 21321191 DOI: 10.1073/pnas.1012753108  0.44
2011 Ma W, Li B, Ling C, Jayandharan GR, Srivastava A, Byrne BJ. A simple method to increase the transduction efficiency of single-stranded adeno-associated virus vectors in vitro and in vivo. Human Gene Therapy. 22: 633-40. PMID 21219084 DOI: 10.1089/hum.2010.243  0.44
2011 Silver JN, Elder M, Conlon T, Cruz P, Wright AJ, Srivastava A, Flotte TR. Recombinant adeno-associated virus-mediated gene transfer for the potential therapy of adenosine deaminase-deficient severe combined immune deficiency. Human Gene Therapy. 22: 935-49. PMID 21142972 DOI: 10.1089/hum.2010.121  0.72
2011 Petrs-Silva H, Dinculescu A, Li Q, Deng WT, Pang JJ, Min SH, Chiodo V, Neeley AW, Govindasamy L, Bennett A, Agbandje-McKenna M, Zhong L, Li B, Jayandharan GR, Srivastava A, et al. Novel properties of tyrosine-mutant AAV2 vectors in the mouse retina. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 293-301. PMID 21045809 DOI: 10.1038/mt.2010.234  0.72
2010 Markusic DM, Herzog RW, Aslanidi GV, Hoffman BE, Li B, Li M, Jayandharan GR, Ling C, Zolotukhin I, Ma W, Zolotukhin S, Srivastava A, Zhong L. High-efficiency transduction and correction of murine hemophilia B using AAV2 vectors devoid of multiple surface-exposed tyrosines. Molecular Therapy : the Journal of the American Society of Gene Therapy. 18: 2048-56. PMID 20736929 DOI: 10.1038/mt.2010.172  0.44
2010 Ojano-Dirain C, Glushakova LG, Zhong L, Zolotukhin S, Muzyczka N, Srivastava A, Stacpoole PW. An animal model of PDH deficiency using AAV8-siRNA vector-mediated knockdown of pyruvate dehydrogenase E1α. Molecular Genetics and Metabolism. 101: 183-91. PMID 20685142 DOI: 10.1016/j.ymgme.2010.07.008  0.72
2010 Ling C, Lu Y, Kalsi JK, Jayandharan GR, Li B, Ma W, Cheng B, Gee SW, McGoogan KE, Govindasamy L, Zhong L, Agbandje-McKenna M, Srivastava A. Human hepatocyte growth factor receptor is a cellular coreceptor for adeno-associated virus serotype 3. Human Gene Therapy. 21: 1741-7. PMID 20545554 DOI: 10.1089/hum.2010.075  0.44
2010 Li M, Jayandharan GR, Li B, Ling C, Ma W, Srivastava A, Zhong L. High-efficiency transduction of fibroblasts and mesenchymal stem cells by tyrosine-mutant AAV2 vectors for their potential use in cellular therapy. Human Gene Therapy. 21: 1527-43. PMID 20507237 DOI: 10.1089/hum.2010.005  0.44
2010 Kauss MA, Smith LJ, Zhong L, Srivastava A, Wong KK, Chatterjee S. Enhanced long-term transduction and multilineage engraftment of human hematopoietic stem cells transduced with tyrosine-modified recombinant adeno-associated virus serotype 2. Human Gene Therapy. 21: 1129-36. PMID 20486772 DOI: 10.1089/hum.2010.016  0.32
2010 Jayandharan GR, Zhong L, Sack BK, Rivers AE, Li M, Li B, Herzog RW, Srivastava A. Optimized adeno-associated virus (AAV)-protein phosphatase-5 helper viruses for efficient liver transduction by single-stranded AAV vectors: therapeutic expression of factor IX at reduced vector doses. Human Gene Therapy. 21: 271-83. PMID 19788390 DOI: 10.1089/hum.2009.100  0.44
2009 Glushakova LG, Lisankie MJ, Eruslanov EB, Ojano-Dirain C, Zolotukhin I, Liu C, Srivastava A, Stacpoole PW. AAV3-mediated transfer and expression of the pyruvate dehydrogenase E1 alpha subunit gene causes metabolic remodeling and apoptosis of human liver cancer cells. Molecular Genetics and Metabolism. 98: 289-99. PMID 19586787 DOI: 10.1016/j.ymgme.2009.05.010  0.36
2009 Lin IJ, Zhou Z, Crusselle-Davis VJ, Moghimi B, Gandhi K, Anantharaman A, Pantic D, Huang S, Jayandharan G, Zhong L, Srivastava A, Bungert J. Calpeptin increases the activity of upstream stimulatory factor and induces high level globin gene expression in erythroid cells. The Journal of Biological Chemistry. 284: 20130-5. PMID 19491096 DOI: 10.1074/jbc.M109.001461  0.72
2009 Petrs-Silva H, Dinculescu A, Li Q, Min SH, Chiodo V, Pang JJ, Zhong L, Zolotukhin S, Srivastava A, Lewin AS, Hauswirth WW. High-efficiency transduction of the mouse retina by tyrosine-mutant AAV serotype vectors. Molecular Therapy : the Journal of the American Society of Gene Therapy. 17: 463-71. PMID 19066593 DOI: 10.1038/mt.2008.269  0.72
2008 Zhong L, Li B, Jayandharan G, Mah CS, Govindasamy L, Agbandje-McKenna M, Herzog RW, Weigel-Van Aken KA, Hobbs JA, Zolotukhin S, Muzyczka N, Srivastava A. Tyrosine-phosphorylation of AAV2 vectors and its consequences on viral intracellular trafficking and transgene expression. Virology. 381: 194-202. PMID 18834608 DOI: 10.1016/j.virol.2008.08.027  0.88
2008 Varki AP, Baum LG, Bellis SL, Cummings RD, Esko JD, Hart GW, Linhardt RJ, Lowe JB, McEver RP, Srivastava A, Sarkar R. Working group report: the roles of glycans in hemostasis, inflammation and vascular biology. Glycobiology. 18: 747-9. PMID 18621991 DOI: 10.1093/glycob/cwn065  0.72
2008 Zhong L, Li B, Mah CS, Govindasamy L, Agbandje-McKenna M, Cooper M, Herzog RW, Zolotukhin I, Warrington KH, Weigel-Van Aken KA, Hobbs JA, Zolotukhin S, Muzyczka N, Srivastava A. Next generation of adeno-associated virus 2 vectors: point mutations in tyrosines lead to high-efficiency transduction at lower doses. Proceedings of the National Academy of Sciences of the United States of America. 105: 7827-32. PMID 18511559 DOI: 10.1073/pnas.0802866105  0.88
2008 Maina N, Zhong L, Li X, Zhao W, Han Z, Bischof D, Aslanidi G, Zolotukhin S, Weigel-Van Aken KA, Rivers AE, Slayton WB, Yoder MC, Srivastava A. Optimization of recombinant adeno-associated viral vectors for human beta-globin gene transfer and transgene expression. Human Gene Therapy. 19: 365-75. PMID 18399730 DOI: 10.1089/hum.2007.173  0.44
2008 Maina N, Han Z, Li X, Hu Z, Zhong L, Bischof D, Weigel-Van Aken KA, Slayton WB, Yoder MC, Srivastava A. Recombinant self-complementary adeno-associated virus serotype vector-mediated hematopoietic stem cell transduction and lineage-restricted, long-term transgene expression in a murine serial bone marrow transplantation model. Human Gene Therapy. 19: 376-83. PMID 18370591 DOI: 10.1089/hum.2007.143  0.4
2008 Han Z, Berendzen K, Zhong L, Surolia I, Chouthai N, Zhao W, Maina N, Srivastava A, Stacpoole PW. A combined therapeutic approach for pyruvate dehydrogenase deficiency using self-complementary adeno-associated virus serotype-specific vectors and dichloroacetate. Molecular Genetics and Metabolism. 93: 381-7. PMID 18206410 DOI: 10.1016/j.ymgme.2007.10.131  0.36
2008 Zhong L, Zhou X, Li Y, Qing K, Xiao X, Samulski RJ, Srivastava A. Single-polarity recombinant adeno-associated virus 2 vector-mediated transgene expression in vitro and in vivo: mechanism of transduction. Molecular Therapy : the Journal of the American Society of Gene Therapy. 16: 290-5. PMID 18087261 DOI: 10.1038/  0.72
2008 Han Z, Zhong L, Srivastava A, Stacpoole PW. Pyruvate dehydrogenase complex deficiency caused by ubiquitination and proteasome-mediated degradation of the E1 subunit. The Journal of Biological Chemistry. 283: 237-43. PMID 17923481 DOI: 10.1074/jbc.M704748200  0.36
2007 Zhong L, Zhao W, Wu J, Li B, Zolotukhin S, Govindasamy L, Agbandje-McKenna M, Srivastava A. A dual role of EGFR protein tyrosine kinase signaling in ubiquitination of AAV2 capsids and viral second-strand DNA synthesis. Molecular Therapy : the Journal of the American Society of Gene Therapy. 15: 1323-30. PMID 17440440 DOI: 10.1038/  0.44
2007 Han Z, Gorbatyuk M, Thomas J, Lewin AS, Srivastava A, Stacpoole PW. Down-regulation of expression of rat pyruvate dehydrogenase E1alpha gene by self-complementary adeno-associated virus-mediated small interfering RNA delivery. Mitochondrion. 7: 253-9. PMID 17392036 DOI: 10.1016/j.mito.2007.02.003  0.72
2007 Wu J, Zhao W, Zhong L, Han Z, Li B, Ma W, Weigel-Kelley KA, Warrington KH, Srivastava A. Self-complementary recombinant adeno-associated viral vectors: packaging capacity and the role of rep proteins in vector purity. Human Gene Therapy. 18: 171-82. PMID 17328683 DOI: 10.1089/hum.2006.088  0.4
2006 Zhong L, Zhao W, Wu J, Maina N, Han Z, Srivastava A. Adeno-associated virus-mediated gene transfer in hematopoietic stem/ progenitor cells as a therapeutic tool. Current Gene Therapy. 6: 683-98. PMID 17168699 DOI: 10.2174/156652306779010660  0.36
2006 Weigel-Kelley KA, Yoder MC, Chen L, Srivastava A. Role of integrin cross-regulation in parvovirus B19 targeting. Human Gene Therapy. 17: 909-20. PMID 16972759 DOI: 10.1089/hum.2006.17.909  0.72
2006 Zhao W, Zhong L, Wu J, Chen L, Qing K, Weigel-Kelley KA, Larsen SH, Shou W, Warrington KH, Srivastava A. Role of cellular FKBP52 protein in intracellular trafficking of recombinant adeno-associated virus 2 vectors. Virology. 353: 283-93. PMID 16828834 DOI: 10.1016/j.virol.2006.04.042  0.72
2006 Zhong L, Li W, Li Y, Zhao W, Wu J, Li B, Maina N, Bischof D, Qing K, Weigel-Kelley KA, Zolotukhin I, Warrington KH, Li X, Slayton WB, Yoder MC, et al. Evaluation of primitive murine hematopoietic stem and progenitor cell transduction in vitro and in vivo by recombinant adeno-associated virus vector serotypes 1 through 5. Human Gene Therapy. 17: 321-33. PMID 16544981 DOI: 10.1089/hum.2006.17.321  0.4
2005 Srivastava A. Hematopoietic stem cell transduction by recombinant adeno-associated virus vectors: problems and solutions. Human Gene Therapy. 16: 792-8. PMID 16000061 DOI: 10.1089/hum.2005.16.792  0.72
2004 Zhong L, Li W, Yang Z, Qing K, Tan M, Hansen J, Li Y, Chen L, Chan RJ, Bischof D, Maina N, Weigel-Kelley KA, Zhao W, Larsen SH, Yoder MC, et al. Impaired nuclear transport and uncoating limit recombinant adeno-associated virus 2 vector-mediated transduction of primary murine hematopoietic cells. Human Gene Therapy. 15: 1207-18. PMID 15684697 DOI: 10.1089/hum.2004.15.1207  0.72
2004 Zhong L, Chen L, Li Y, Qing K, Weigel-Kelley KA, Chan RJ, Yoder MC, Srivastava A. Self-complementary adeno-associated virus 2 (AAV)-T cell protein tyrosine phosphatase vectors as helper viruses to improve transduction efficiency of conventional single-stranded AAV vectors in vitro and in vivo. Molecular Therapy : the Journal of the American Society of Gene Therapy. 10: 950-7. PMID 15509512 DOI: 10.1016/j.ymthe.2004.07.018  0.72
2004 Zhong L, Qing K, Si Y, Chen L, Tan M, Srivastava A. Heat-shock treatment-mediated increase in transduction by recombinant adeno-associated virus 2 vectors is independent of the cellular heat-shock protein 90. The Journal of Biological Chemistry. 279: 12714-23. PMID 14711833 DOI: 10.1074/jbc.M310548200  0.32
2003 Weigel-Kelley KA, Yoder MC, Srivastava A. α5β1 integrin as a cellular coreceptor for human parvovirus B19: Requirement of functional activation of β1 integrin for viral entry Blood. 102: 3927-3933. DOI: 10.1182/blood-2003-05-1522  0.72
2001 Tan M, Qing K, Zhou S, Yoder MC, Srivastava A. Adeno-associated virus 2-mediated transduction and erythroid lineage-restricted long-term expression of the human β-globin gene in hematopoietic cells from homozygous β-thalassemic mice Molecular Therapy. 3: 940-946. PMID 11407908 DOI: 10.1006/mthe.2001.0346  0.72
2000 Hansen J, Qing K, Kwon HJ, Mah C, Srivastava A. Impaired intracellular trafficking of adeno-associated virus type 2 vectors limits efficient transduction of murine fibroblasts Journal of Virology. 74: 992-996. PMID 10623762 DOI: 10.1128/JVI.74.2.992-996.2000  0.72
1999 Kurpad C, Mukherjee P, Wang XUS, Ponnazhagan S, Li L, Yoder MC, Srivastava A. Adeno-associated virus 2-mediated transduction and erythroid lineage- restricted expression from parvovirus B19p6 promoter in primary human hematopoietic progenitor cells Journal of Hematotherapy and Stem Cell Research. 8: 585-592. PMID 10645765 DOI: 10.1089/152581699319740  0.72
1997 Grant CA, Ponnazhagan S, Wang XS, Srivastava A, Li T. Evaluation of recombinant adeno-associated virus as a gene transfer vector for the retina. Current Eye Research. 16: 949-56. PMID 9288458 DOI: 10.1076/ceyr.16.9.949.5046  0.72
1996 Ponnazhagan S, Wang XS, Woody MJ, Luo F, Kang LY, Nallari ML, Munshi NC, Zhou SZ, Srivastava A. Differential expression in human cells from the p6 promoter of human parvovirus B19 following plasmid transfection and recombinant adeno-associated virus 2 (AAV) infection: human megakaryocytic leukaemia cells are non-permissive for AAV infection. The Journal of General Virology. 77: 1111-22. PMID 8683195 DOI: 10.1099/0022-1317-77-6-1111  0.72
1995 Wang XS, Yoder MC, Zhou SZ, Srivastava A. Parvovirus B19 promoter at map unit 6 confers autonomous replication competence and erythroid specificity to adeno-associated virus 2 in primary human hematopoietic progenitor cells Proceedings of the National Academy of Sciences of the United States of America. 92: 12416-12420. PMID 8618912 DOI: 10.1073/pnas.92.26.12416  0.72
1994 Szekeres T, Gharehbaghi K, Fritzer M, Woody M, Srivastava A, van't Riet B, Jayaram HN, Elford HL. Biochemical and antitumor activity of trimidox, a new inhibitor of ribonucleotide reductase. Cancer Chemotherapy and Pharmacology. 34: 63-6. PMID 8174204 DOI: 10.1007/BF00686113  0.72
1994 Borrow J, Shipley J, Howe K, Kiely F, Goddard A, Sheer D, Srivastava A, Antony AC, Fioretos T, Mitelman F. Molecular analysis of simple variant translocations in acute promyelocytic leukemia. Genes, Chromosomes & Cancer. 9: 234-43. PMID 7519045 DOI: 10.1002/gcc.2870090403  0.72
1990 Srivastava A, Shmookler Reis RJ, Goldstein S. Absence of reverse transcriptase activity in human diploid fibroblasts Mechanisms of Ageing and Development. 51: 133-138. PMID 1689785 DOI: 10.1016/0047-6374(90)90095-W  0.72
1985 Goldstein S, Srivastava A, Riabowol KT, Shmookler Reis RJ. Changes in genetic organization and expression in aging cells. Basic Life Sciences. 35: 255-67. PMID 4062813 DOI: 10.1007/978-1-4899-2218-2_16  0.72
1985 Shmookler Reis RJ, Srivastava A, Beranek DT, Goldstein S. Human alphoid family of tandemly repeated DNA. Sequence of cloned tetrameric fragments and analysis of familial divergence Journal of Molecular Biology. 186: 31-41. PMID 3001316 DOI: 10.1016/0022-2836(85)90254-2  0.72
1984 Muzyczka N, Samulski RJ, Hermonat P, Srivastava A, Berns KI. The genetics of adeno-associated virus. Advances in Experimental Medicine and Biology. 179: 151-61. PMID 6098150 DOI: 10.1007/978-1-4684-8730-5_15  0.72
1983 Srivastava A, Lusby EW, Berns KI. Nucleotide sequence and organization of the adeno-associated virus 2 genome. Journal of Virology. 45: 555-64. PMID 6300419  0.72
1983 Samulski RJ, Srivastava A, Berns KI, Muzyczka N. Rescue of adeno-associated virus from recombinant plasmids: gene correction within the terminal repeats of AAV. Cell. 33: 135-43. PMID 6088052 DOI: 10.1016/0092-8674(83)90342-2  0.72
Show low-probability matches.